Table 1 Baseline characteristics of patients referred to the NAFLD care pathway 8/1/2017–1/31/2018
Population characteristic | Total |
|---|---|
Study population referred to NAFLD Care Pathway 8/1/2017–1/31/2018 | 632 |
Gender, N (%) | |
 Male | 274 (43.4%) |
 Female | 358 (56.7%) |
Mean age (SD) years | 53.7 (13.0) |
Race/ethnicity, N (%) | |
 White | 271 (42.9%) |
 Hispanic | 247 (39.1%) |
 Asian | 66 (10.4) |
 Black | 20 (3.2%) |
 Other/unknown/multiple | 28 (4.4%) |
Mean BMI (SD) kg/m2 | 34.0 (6.8) |
Diabetes/Prediabetes, N (%) | 206 (32.6%) |
Dyslipidemia, N (%) | 377 (59.7%) |
HTN, N (%) | 305 (48.3%) |
Cardiovascular Disease, N (%) | 62 (9.8%) |
ALT U/L, mean (SD) (N = 602) | 59.4 (42.9) |
AST U/L, mean (SD) (N = 405) | 41.8 (36.4) |
GGT U/L, mean (SD) (N = 384) | 78.3 (104.2) |
Albumin g/dL, mean (SD) (N = 198) | 3.9 (0.3) |
Total Bilirubin mg/dL, mean (SD) (N = 520) | 0.7 (0.4) |
Platelet count (× 109/L) mean (SD) (N = 517) | 240.1 (72.0) |
INR, mean (SD) (N = 171) | 1.0 (0.3) |
Ferritin ng/mL, mean (SD) (N = 228) | 239.9 (255.5) |
HgbA1c %, mean (SD) (N = 556) | 6.3 (1.2) |
Total Cholesterol mg/dL, mean (SD) (N = 479) | 182.7 (44.6) |
LDL mg/dL, mean (SD) (N = 467) | 107.2 (36.9) |
HDL mg/dL, mean (SD) (N = 479) | 45.4 (11.5) |
Triglycerides mg/dL, mean (SD) (N = 329) | 176.8 (253.8) |